JPMorgan Chase & Co’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $685K | Sell |
|
|||||
|
2025
Q1 | $790K | Sell |
|
|||||
|
2024
Q4 | $1.37M | Sell |
|
|||||
|
2024
Q3 | $1.53M | Sell |
|
|||||
|
2024
Q2 | $2.18M | Sell |
|
|||||
|
2024
Q1 | $2.95M | Sell |
|
|||||
|
2023
Q4 | $2.73M | Buy |
|
|||||
|
2023
Q3 | $2.44M | Sell |
|
|||||
|
2023
Q2 | $4.07M | Sell |
|
|||||
|
2023
Q1 | $2.77M | Buy |
|
|||||
|
2022
Q4 | $1.96M | Hold |
|
|||||
|
2022
Q3 | $1.91M | Buy |
|
|||||
|
2022
Q2 | $1.68M | Sell |
|
|||||
|
2022
Q1 | $2.67M | Sell |
|
|||||
|
2021
Q4 | $1.4M | Sell |
|
|||||
|
2021
Q3 | $2.06M | Sell |
|
|||||
|
2021
Q2 | $3.8M | Sell |
|
|||||
|
2021
Q1 | $6.35M | Buy |
|
|||||
|
2020
Q4 | $4.38M | Buy |
|
|||||
|
2020
Q3 | $3.91M | Buy |
|
|||||
|
2020
Q2 | $4.02M | Buy |
|
|||||
|
2020
Q1 | $2.67M | Buy |
|
|||||
|
2019
Q4 | $3.19M | Buy |
|
|||||
|
2019
Q3 | $3.43M | Sell |
|
|||||
|
2019
Q2 | $8.59M | Buy |
|
|||||
|
2019
Q1 | $4.88M | Sell |
|
|||||
|
2018
Q4 | $2.71M | Buy |
|
|||||
|
2018
Q3 | $4.29M | Buy |
|
|||||
|
2018
Q2 | $4.16M | Buy |
|
|||||
|
2018
Q1 | $3.07M | Buy |
|
|||||
|
2017
Q4 | $669K | Buy |
|
|||||
|
2017
Q3 | $270K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $2.16M | Sell |
|
|||||
|
2016
Q4 | $2.62M | Sell |
|
|||||
|
2016
Q3 | $2.54M | Sell |
|
|||||
|
2016
Q2 | $3.17M | Buy |
|
|||||
|
2016
Q1 | $928K | Sell |
|
|||||
|
2015
Q4 | $2.49M | Buy |
|